Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 46

Results For "net-profit"

577 News Found

Vikas Lifecare consolidated Q1FY23 PAT at Rs. 2.59 Cr
News | July 26, 2022

Vikas Lifecare consolidated Q1FY23 PAT at Rs. 2.59 Cr

The company has reported total income of Rs. 94.30 crores during the period ended June 30, 2022.


GlaxoSmithKline Pharmaceuticals Q1FY23 consolidated PAT at Rs. 119.28 Cr
News | July 26, 2022

GlaxoSmithKline Pharmaceuticals Q1FY23 consolidated PAT at Rs. 119.28 Cr

GlaxoSmithKline Pharmaceuticals has reported total income of Rs. 772.71 crores during the period ended June 30, 2022


Sanofi India Q2 CY2022 PAT drops 49.5% to Rs. 120.4 Cr
News | July 26, 2022

Sanofi India Q2 CY2022 PAT drops 49.5% to Rs. 120.4 Cr

Sanofi India has reported total income of Rs. 715 crores during the period ended June 30, 2022.


IOL Chemicals and Pharmaceuticals Q4 FY2022 PAT drops to Rs. 27.75 Cr
News | June 08, 2022

IOL Chemicals and Pharmaceuticals Q4 FY2022 PAT drops to Rs. 27.75 Cr

The company has posted net profit of Rs.165.66 crores for the Financial Year ended March 31, 2022


Aurobindo Pharma Q4 PAT drops 28% to Rs 576 Cr
News | June 06, 2022

Aurobindo Pharma Q4 PAT drops 28% to Rs 576 Cr

Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore


Glenmark Pharma reports revenue growth of 5.6% YoY in Q4
News | May 30, 2022

Glenmark Pharma reports revenue growth of 5.6% YoY in Q4

Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022


Strides Pharma Science Q4FY22 consolidated PAT at Rs. 29.21 Cr
News | May 26, 2022

Strides Pharma Science Q4FY22 consolidated PAT at Rs. 29.21 Cr

The company has posted net loss of Rs. 460.21 crores for the Financial Year ended March 31, 2022.


Max Healthcare Institute Q4 FY2022 consolidated PAT slips QoQ to Rs. 123.73 Cr
News | May 25, 2022

Max Healthcare Institute Q4 FY2022 consolidated PAT slips QoQ to Rs. 123.73 Cr

The company has posted net profit of Rs.605.05 crores for the Financial Year ended March 31, 2022


IPCA Laboratories posts Rs. 130.23 crores consolidated profit in Q4FY22
News | May 25, 2022

IPCA Laboratories posts Rs. 130.23 crores consolidated profit in Q4FY22

The company has posted net profit of Rs.884.08 crores for the Financial Year ended March 31, 2022.


Cipla posts consolidated PAT of Rs. 362.07 crore in Q4 FY2022
News | May 11, 2022

Cipla posts consolidated PAT of Rs. 362.07 crore in Q4 FY2022

Cipla has reported consolidated financial results for the period ended March 31, 2022